Orwin John A
SEC insider (Form 3/4/5 filer). CIK 0001477384. Director at ANAPTYSBIO, INC (ANAB) and 3 other issuers. 38 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SAN DIEGO, CA.
Companies Orwin John A has filed insider reports for
- ANAPTYSBIO, INC (ANAB): Director
- First Tracks Biotherapeutics, Inc. (TRAX): Director
- Travere Therapeutics, Inc. (TVTX): Director
- CARGO Therapeutics, Inc. (CRGX): Director
Orwin John A
CIK: 0001477384
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (38 total)
- Sep 15, 2026ANAB
ANAPTYSBIO, INC
ExerciseDirect1.3K shares- - Sep 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
ExerciseDirect1.3K shares- - Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
ExerciseDirect6K shares- - Jun 15, 2026ANAB
ANAPTYSBIO, INC
ExerciseDirect6K shares- - May 19, 2026TVTX
Travere Therapeutics, Inc.
AwardDirect4K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectRestricted Stock Unit
15K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
42K shares- - Apr 20, 2026ANAB
ANAPTYSBIO, INC
AwardDirectStock Option (right to buy)
3.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  ANAB ANAPTYSBIO, INC | Exercise | 1,300 | - | $0 | Direct |
| Sep 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise | 1,300 | - | $0 | Direct |
| Jun 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Exercise | 6,030 | - | $0 | Direct |
| Jun 15, 2026 | ANAB ANAPTYSBIO, INC | Exercise | 6,030 | - | $0 | Direct |
| May 19, 2026 |  TVTX Travere Therapeutics, Inc. | Award | 4,000 | - | $0 | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Restricted Stock Unit | 15,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| Apr 20, 2026 | ANAB ANAPTYSBIO, INC | Award Stock Option (right to buy) | 3,311 | - | - | Direct |
1-10 of 38 transactions